3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
11
Gastrointestinal
3
Thoracic
2
Genitourinary
2
Plasma cell
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Conditions
Thyroid Neoplasms
1
Thyroid Diseases
1
Prostatic Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
8
Zoledronic Acid
5
Therapeutics
5
Flow Cytometry
5
pembrolizumab
3
fludarabine
3
Specimen Handling
3
Radiotherapy
3
Peripheral Blood Stem Cell Transplantation
3
Immunologic Techniques
3
Gemcitabine
3
Amplified Fragment Length Polymorphism Analysis
3
venetoclax
2
trametinib
2
ruxolitinib
2
pertuzumab
2
palbociclib
2
liposomal doxorubicin
2
liposomal amphotericin B
2
dabrafenib
2
copanlisib
2
aldesleukin
2
abiraterone
2
Vorinostat
2
Trastuzumab
2
Surveys and Questionnaires
2
Sunitinib
2
Sorafenib
2
Rituximab
2
Psychiatric Rehabilitation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Focus Groups
×
Plasma cell
×
Clear all
NCT06236373
2024-12-09
Survivorship
University of Modena and Reggio Emilia
Recruiting
45 enrolled